Clopidogrel Tablets — Class II drug recall D-0787-2021
Terminated recall by Macleods Pharma Usa Inc, reported 2021-09-08, distributed nationwide. Presence of foreign matter
| Recall number | D-0787-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Macleods Pharma Usa Inc, Plainsboro, NJ, United States |
| Recall initiated | 2021-08-02 |
| Classified | 2021-08-31 |
| Reported by FDA | 2021-09-08 |
| Terminated | 2022-12-02 |
| Distributed | Nationwide (US) |
| Reason classes | foreign material |
| NDC | 33342-0060, 33342-0060-07, 33342-0060-10, 33342-0060-12, 33342-0060-15, 33342-0060-44 |
| Lot numbers | BCA82021A |
| Expiration dates | 2023-06 |
Product
Clopidogrel Tablets, USP, 75 mg, 500-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceutical Ltd., Baddi, Himachal, Pradesh, INDIA NDC 33342-060-15
Reason for recall
Presence of foreign matter
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0787-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.